US Broker Ratings

Ionis Pharmaceuticals (IONS): Investor Outlook on a Biotech Innovator with 27.76% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out as a compelling player in the biotechnology sector, promising significant potential upside for investors intrigued by its innovative pipeline..

RadNet, Inc. (RDNT) Investor Outlook: A 52.96% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) presents a compelling opportunity for investors with its robust position in the healthcare sector, specifically within the diagnostics and research industry. Headquartered..

Exact Sciences Corporation (EXAS) Investor Outlook: Analyzing the Growth Potential and Analyst Consensus

Exact Sciences Corporation (NASDAQ: EXAS) has positioned itself as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: 26% Potential Upside Fuels Investor Interest

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the spotlight in the biotechnology sector with its promising therapeutic developments and substantial growth potential. As a leading player..

GSK plc (GSK): Investor Outlook Shows Modest Upside Amid Strong Revenue Growth

GSK plc (GSK) stands as a stalwart in the healthcare sector, specializing in drug manufacturing. With a market capitalization of $117.55 billion, GSK is a formidable..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring an 86% Potential Upside in the Biotechnology Sector

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, is capturing investor attention with a compelling potential upside of 86.19%. With a current..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 26.86% Upside Potential in the Healthcare Sector

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, stands out with a potential upside of 26.86%, attracting the attention of savvy investors. Headquartered in..

ICON plc (ICLR) Stock Analysis: Potential Upside with Strategic Global Reach Captivates Investors

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. With its headquarters in Dublin, Ireland,..

Vaxcyte, Inc. (PCVX) Investor Outlook: A Deep Dive into Its 74.82% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX) is making waves in the biotechnology sector with its promising pipeline of vaccines aimed at combating bacterial infectious diseases. As a clinical-stage..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating the Biotech with a $2.73 Billion Market Cap and Promising Rare Disease Focus

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making waves in the biotechnology sector with a market capitalization of $2.73 billion. Based in Redwood City, California, this biopharmaceutical..

McKesson Corporation (MCK) Stock Report: Analyst Ratings Signal a 14.46% Upside

Investors eyeing the healthcare sector might find McKesson Corporation (NYSE: MCK) an intriguing prospect. As a leading player in medical distribution, McKesson is a cornerstone in..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a Promising 10% Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a noteworthy consideration for investors with its potential upside of 10.14%, as highlighted by recent analyst ratings...

Johnson & Johnson (JNJ) Stock Analysis: Revenue Growth and Analyst Insights Suggest a Promising 7.22% Upside

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to capture the attention of investors with its robust market presence and promising growth..

Bruker Corporation (BRKR) Stock Analysis: Navigating Market Dynamics with a Potential 14.95% Upside

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector’s medical devices industry, presents a compelling narrative for investors eyeing growth in scientific instrumentation and..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Unlocking 15% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, stands as Japan’s largest pharmaceutical firm and one of the global leaders in the..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unveiling a 39.92% Potential Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out in the healthcare sector with a robust portfolio focused on neurological, psychiatric, endocrine, and immunological disorders. With a market..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unveiling a 40% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, is capturing investor attention with its promising 40.22% potential upside. Headquartered in South..

Pfizer Inc. (PFE) Investor Outlook: Navigating a 6.24% Dividend Yield Amidst Sector Challenges

Pfizer Inc. (NYSE: PFE), a giant in the healthcare sector, presents a unique opportunity for investors with its robust dividend yield of 6.24%. Despite facing challenges..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 21.96% Upside Potential

argenx SE (ARGX), a leading name in the biotechnology sector, has emerged as a formidable contender in the healthcare industry. With a market capitalization of $53.06..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds